Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H OERTEL

Showing results (351-360 of 678) with videos related to

Pageof 68
Sort By:
Brain Research|December 5, 1998
Rat fetal ventral mesencephalon grown as solid tissue cultures: influence of culture time and BDNF treatment on dopamine neuron survival and functionG U Höglinger, J Sautter, M Meyer, et al.
Medizinische Klinik (Munich, Germany : 1983)|July 15, 1996
[Costs of drug treatment of neurologic diseases: Parkinson disease, dystonia, epilepsy]R C Dodel, S Pepperl, R Köhne-Volland, et al.
The Lancet. Neurology|May 19, 2007
Efficacy of pramipexole and transdermal rotigotine in advanced Parkinson's disease: a double-blind, double-dummy, randomised controlled trialWerner H Poewe, Olivier Rascol, Niall Quinn, et al.
Journal of Parkinson'S Disease|August 14, 2013
The α7 nAChR agonist PNU-282987 reduces inflammation and MPTP-induced nigral dopaminergic cell loss in miceVanessa Stuckenholz, Michael Bacher, Monika Balzer-Geldsetzer, et al.
Sleep Medicine|March 24, 2006
Sudden onset of sleep and dopaminergic therapy in patients with restless legs syndromeJens Carsten Möller, Yvonne Körner, Werner Cassel, et al.
Neuroimage|May 2, 2013
Effect of long-term treatment with pramipexole or levodopa on presynaptic markers assessed by longitudinal [123I]FP-CIT SPECT and histochemistryCandan Depboylu, Lukas Maurer, Andreas Matusch, et al.
Frontiers in Aging Neuroscience|April 18, 2022
Reduction in Volume of Nucleus Basalis of Meynert Is Specific to Parkinson's Disease and Progressive Supranuclear Palsy but Not to Multiple System AtrophySophia Rogozinski, Martin Klietz, Gesine Respondek, et al.
Journal of Neurology|January 29, 2005
Restless legs syndrome--new insights into clinical characteristics, pathophysiology, and treatment optionsK Stiasny-Kolster, C Trenkwalder, W Fogel, et al.
Experimental Neurology|February 13, 2001
Influence of time in culture and BDNF pretreatment on survival and function of grafted embryonic rat ventral mesencephalon in the 6-OHDA rat model of Parkinson's diseaseG U Höglinger, H R Widmer, C Spenger, et al.
Journal of Neuroimmunology|June 7, 2011
Upregulation of microglial C1q expression has no effects on nigrostriatal dopaminergic injury in the MPTP mouse model of Parkinson diseaseCandan Depboylu, Kathrin Schorlemmer, Martin Klietz, et al.
Pageof 68

Showing results (351-360 of 678) with videos related to

Sort By:
Pageof 68
Brain Research|December 5, 1998
Rat fetal ventral mesencephalon grown as solid tissue cultures: influence of culture time and BDNF treatment on dopamine neuron survival and functionG U Höglinger, J Sautter, M Meyer, et al.
Medizinische Klinik (Munich, Germany : 1983)|July 15, 1996
[Costs of drug treatment of neurologic diseases: Parkinson disease, dystonia, epilepsy]R C Dodel, S Pepperl, R Köhne-Volland, et al.
The Lancet. Neurology|May 19, 2007
Efficacy of pramipexole and transdermal rotigotine in advanced Parkinson's disease: a double-blind, double-dummy, randomised controlled trialWerner H Poewe, Olivier Rascol, Niall Quinn, et al.
Journal of Parkinson'S Disease|August 14, 2013
The α7 nAChR agonist PNU-282987 reduces inflammation and MPTP-induced nigral dopaminergic cell loss in miceVanessa Stuckenholz, Michael Bacher, Monika Balzer-Geldsetzer, et al.
Sleep Medicine|March 24, 2006
Sudden onset of sleep and dopaminergic therapy in patients with restless legs syndromeJens Carsten Möller, Yvonne Körner, Werner Cassel, et al.
Neuroimage|May 2, 2013
Effect of long-term treatment with pramipexole or levodopa on presynaptic markers assessed by longitudinal [123I]FP-CIT SPECT and histochemistryCandan Depboylu, Lukas Maurer, Andreas Matusch, et al.
Frontiers in Aging Neuroscience|April 18, 2022
Reduction in Volume of Nucleus Basalis of Meynert Is Specific to Parkinson's Disease and Progressive Supranuclear Palsy but Not to Multiple System AtrophySophia Rogozinski, Martin Klietz, Gesine Respondek, et al.
Journal of Neurology|January 29, 2005
Restless legs syndrome--new insights into clinical characteristics, pathophysiology, and treatment optionsK Stiasny-Kolster, C Trenkwalder, W Fogel, et al.
Experimental Neurology|February 13, 2001
Influence of time in culture and BDNF pretreatment on survival and function of grafted embryonic rat ventral mesencephalon in the 6-OHDA rat model of Parkinson's diseaseG U Höglinger, H R Widmer, C Spenger, et al.
Journal of Neuroimmunology|June 7, 2011
Upregulation of microglial C1q expression has no effects on nigrostriatal dopaminergic injury in the MPTP mouse model of Parkinson diseaseCandan Depboylu, Kathrin Schorlemmer, Martin Klietz, et al.
Pageof 68